跳至主要内容
临床试验/ISRCTN78982321
ISRCTN78982321已完成不适用

A multicentre randomised study of dose-intensive chemotherapy as primary treatment in a multimodality approach for locally advanced or inflammatory breast cancer

European Organisation for Research and Treatment of Cancer (EORTC) (Belgium)0 个研究点目标入组 400 人开始时间: 2002年8月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Female patients with histologically confirmed breast cancer in the following subgroups:
  • 1.1. T4 Nx
  • 1.2. Any N2 or N3, M0
  • 1.3. Clinically inflammatory breast carcinoma defined as redness over at least one-third of the breast
  • 1.4. M0 except for ipsilateral supraclavicular nodes
  • 2. No evidence of tumour spread other than as defined above
  • 3. No previous surgical, systemic or radiation treatment for breast cancer, other than biopsy for confirmation of the diagnosis
  • 4. World Health Organisation (WHO) performance status zero to two
  • 5. Adequate renal, hepatic and haematological function
  • 6. No previous or concomitant malignancy except adequately treated squamous or basal cell carcinoma of the skin, or adequately treated cone-biopsied in situ carcinoma of the cervix uteri
  • 7. No significant cardiac disease

排除标准

  • Does not match inlcusion criteria

研究者

发起方
European Organisation for Research and Treatment of Cancer (EORTC) (Belgium)

相似试验